Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis

Costs of pharmacotherapy in pediatric patients with community-acquired pneumonia: mathematical and statistical analysis

The aim of the study is to determine the limits of using the mathematical-statistical analysis for the evaluation of pharmacotherapy costs in pediatric inpatients diagnosed with community-acquired pneumonia. Materials and methods. The report is based on the assessment of 547 medical records of patie...

Full description

Bibliographic Details
Main Authors:	I. A. Narkevich, O. D. Nemyatyh, D. D. Siukaeva, I. V. Pavlushkov, D. O. Ivanov, Ya. V. Panyutina
Format:	Article
Language:	Russian
Published:	IRBIS LLC 2019-01-01
Series:	Фармакоэкономика
Subjects:	сommunity-acquired pneumonia pediatrics correlation analysis analysis of variance regression analysis inpatient care
Online Access:	https://www.pharmacoeconomics.ru/jour/article/view/269

Similar Items

Use of medications in children hospitalized with community-acquired pneumonia
by: D. D. Siukaeva, et al.
Published: (2018-11-01)

Influence of antibiotics of different groups on the course of community-acquired pneumonia in children
by: N.Yu. Shcherbatiuk, et al.
Published: (2022-12-01)

Pharmacoeconomic research of pharmacotherapy schemes of community-acquired pneumonia with the inclusion of antiviral drugs
by: S. O. Soloviov, et al.
Published: (2020-03-01)

COMPREHENSIVE ASSESSMENT OF THE MARKET DRUGS FOR TREATMENT OF PNEUMONIA IN PEDIATRICS
by: D. D. Siukaeva, et al.
Published: (2019-01-01)

Analysis of antiviral use efficiency criteria in the complex pharmacotherapy of community acquired pneumonia
by: S. O. Soloviov, et al.
Published: (2019-03-01)

Features of laboratory indicators of severe community-acquired pneumonia
by: Pertzeva T.A., et al.
Published: (2017-06-01)

Тhe features of severe community acquired pneumonia
by: Avramenko I.V.
Published: (2015-06-01)

chlamydia pneumoniae unfection in - patients with community acquired pneumonia in Iraq
by: hayfaa D. Salman
Published: (2009-01-01)

Role and place of levofloxacin in the treatment of community-acquired pneumonia
by: D V Dmytriiev, et al.
Published: (2021-03-01)

Manuel Сastells’ concept of the power of communication in the scientific discourse of digital sociology
by: M. V. Kibakin, et al.
Published: (2020-10-01)

Community-acquired pneumonia /
by: Suttorp, N. (Norbert), 1953-, et al.
Published: (2007)

Risk factors for community-acquired pneumonia among inpatients with mental disorders in a tertiary general hospital
by: Jingjing Han, et al.
Published: (2022-07-01)

Characteristics and etiology of hospitalized pediatric community-acquired pneumonia in Taiwan
by: Hsin Chi, et al.
Published: (2020-10-01)

Sputum Gram stain for diagnosing causative bacterial pathogens and guiding antimicrobial therapies in community-acquired pneumonia: a systematic review and meta-analysis protocol
by: Hiroaki Ogawa, et al.
Published: (2019-08-01)

NEW ASPECTS OF THE USE OF PROTEIN TISSUE-SPECIFIC MARKERS IN THE ESTIMATION OF SEVERITY OF COMMUNITY-ACQUIRED PNEUMONIA
by: M. I. Voevoda, et al.
Published: (2019-09-01)

Hospital Acquired Pneumonia
by: Halis AKALIN, et al.
Published: (1999-12-01)

Dilemma of community-acquired pneumonia
by: Lamia H Shaaban
Published: (2019-01-01)

Data in Brief of: Clinical benefits of moxifloxacin as initial treatment of community-acquired pneumonia: Data from meta-analyses
by: Xiwen Du, et al.
Published: (2021-10-01)

IDENTIFIKASI DRUG RELATED PROBLEMs (DRPs) PADA PASIEN PEDIATRI PNEUMONIA KOMUNITAS DI INSTALASI RAWAT INAP RSD MADANI PROVINSI SULAWESI TENGAH
by: Putu Maharani Ajeng Astiti, et al.
Published: (2017-03-01)

Cytokine profile in community-acquired pneumonia in children
by: N. V. Iziurova, et al.
Published: (2022-11-01)

Nonlinear main components of the cytokine profile in children with community-acquired pneumonia
by: N. V. Iziurova, et al.
Published: (2024-01-01)

Methodology of Work on The Presentation And Composition: Text-centric Approach
Published: (2014-04-01)

THE USE OF BALANCED SCORECARD TO EVALUATE THE SKILLS OF COMMUNICATION SYSTEM WORKERS OF ENTERPRISES
by: Юлія Богданівна МОЛОЧНИК
Published: (2015-05-01)

CHARACTERIZATION OF THE AVERAGE POWER, FREQUENCY AND AMPLITUDE OF ACOUSTIC SIGNAL PEAKS OVER THE LUNGS IN CHILDREN WITH COMMUNITY-ACQUIRED PNEUMONIA USING THE NEW DEVICE "TREMBITA-CORONA"
by: Yu. Marushko, et al.
Published: (2023-03-01)

Integrative population pharmacokinetic/pharmacodynamic analysis of nemonoxacin capsule in Chinese patients with community-acquired pneumonia
by: Yuancheng Chen, et al.
Published: (2023-02-01)

Mycoplasma pneumonia and Chlamydia pneumonia infection in patients admitted to Beheshti Hospital in Kashan with community-acquired pneumonia
by: Mansoreh Momen Heravi, et al.
Published: (2023-12-01)

Disease burden of intensive care unit-acquired pneumonia in China: a systematic review and meta-analysis
by: Yaowen Zhang, et al.
Published: (2014-12-01)

Comparison between Ceftriaxone and Sulbactam-Ampicillin as Initial Treatment of Community-Acquired Pneumonia: A Systematic Review and Meta-Analysis
by: Hideo Kato, et al.
Published: (2022-09-01)

Distribution of Clinical Traditional Chinese Medicine Syndromes in Patients with Severe Community-acquired Pneumonia
by: Chenxi ZHANG, Shengnan GUAN, Kai XIE, Kang ZHANG, Haifeng WANG
Published: (2022-07-01)

Etiology of community-acquired pneumonia in the military personnel
by: Speranskaya E.V., et al.
Published: (2018-05-01)

Tigecycline and Community-Acquired Pneumonia
by: Sercan ULUSOY
Published: (2013-12-01)

PES Pathogens in Severe Community-Acquired Pneumonia
by: Catia Cillóniz, et al.
Published: (2019-02-01)

Pattern of community and hospital acquired pneumonia in Egyptian military hospitals
by: Magdy Mohammad Khalil, et al.
Published: (2013-01-01)

Incidence of Antibiotic Treatment Failure in Patients with Nursing Home-Acquired Pneumonia and Community Acquired Pneumonia
by: Mariana Lopes, et al.
Published: (2021-01-01)

The effect of taking antibacterial therapy on the outpatient stage and outcomes of community-acquired pneumonia in Tomsk hospitals
by: Daria A. Vinokurova, et al.
Published: (2024-01-01)

Molecular Distance to Health Transcriptional Score and Disease Severity in Children Hospitalized With Community-Acquired Pneumonia
by: Rebecca G. Wallihan, et al.
Published: (2018-10-01)

Detection of Mycoplasma pneumoniae in Mexican children with community-acquired pneumonia: experience in a tertiary care hospital
by: Merida-Vieyra J, et al.
Published: (2019-04-01)

Analysis of intra annual spatial dynamics of community-aсquired pneumonia incidence in the urban environment
by: N. A. Kravchenko, et al.
Published: (2022-09-01)

DIAGNOSTIC VALUE OF PROCALCITONIN, C-REACTIVE PROTEIN AND TRANS-RESONANT FUNCTIONAL TOPOGRAPHY IN THE COURSE OF COMMUNITY-ACQUIRED PNEUMONIA
by: A.V. Konkov, et al.
Published: (2008-09-01)

Mycoplasma pneumoniae: Atypical Pathogen in Community Acquired Pneumonia
by: Abdul-Rahman Mamdouh Mohammad, et al.
Published: (2020-12-01)